Jyothy Labs Limited's Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, at their meeting held on May 12, 2025.
For the financial year ended March 31, 2025, the company reported consolidated revenue from operations of ₹2,84,698 lacs and a consolidated net profit of ₹37,038 lacs.
The Basic Earnings Per Share (EPS) on a consolidated basis for the year was ₹10.09.
The board has recommended a final dividend of ₹3.50 per equity share of Re. 1/- each for the financial year 2024-25. This recommendation is subject to the approval of shareholders at the ensuing Annual General Meeting (AGM).
An exceptional item, related to the sale of the company's entire equity stake in Jyothy Kallol Bangladesh Limited (JKBL), resulted in a consolidated loss of ₹430 lacs. JKBL ceased to be a subsidiary from March 25, 2025.
The Auditor's Report issued by M/s. B S R & Co. LLP on the audited financial results has an unmodified opinion.
During the quarter ended March 31, 2025, the company issued 5,867 equity shares upon exercise of stock options under the Employees Stock Unit Plan – 2023, increasing the paid-up equity share capital.